Associations between vitamin D receptor genotypes and mortality in a cohort of older Dutch individuals

European Journal of Endocrinology

Volumn 164, Issue 1, 2011, Pages 75-82

  De Jongh, Renate T ^a   Lips, Paul ^a   Rijs, Kelly J ^a   Van Schoor, Natasja M ^a   Kramer, Mark H H ^a   Vandenbroucke, Jan P ^b   Dekkers, Olaf M ^b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; TRANSCRIPTION FACTOR CDX2; TRANSCRIPTION FACTOR GATA; VITAMIN D RECEPTOR; GENE PRODUCT; PROTEIN APAI; PROTEIN BSMI; PROTEIN FOKI; PROTEIN TAQI; UNCLASSIFIED DRUG;

ADULT; AGED; AGING; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DNA DETERMINATION; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NETHERLANDS; OSTEOPOROSIS; PRIORITY JOURNAL; COHORT ANALYSIS; COPY NUMBER VARIATION; DNA POLYMORPHISM; FRAGILITY FRACTURE; GENE FREQUENCY; GENETIC RISK; POPULATION RESEARCH; PROSPECTIVE STUDY; VITAMIN BLOOD LEVEL;

AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; COHORT STUDIES; DEOXYRIBONUCLEASES, TYPE II SITE-SPECIFIC; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HOMEODOMAIN PROTEINS; HUMANS; LEUCINE; MALE; MIDDLE AGED; MORTALITY; NEOPLASMS; NETHERLANDS; ODDS RATIO; POLYMORPHISM, GENETIC; RECEPTORS, CALCITRIOL; RISK ASSESSMENT; RISK FACTORS;

EID: 78751534361     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-10-0688     Document Type: Article

References (39)

1. 3 in the pancreas. Cell and Tissue Research 1980 209 515-520. (doi:10.1007/BF00234764)
2. 3 modulates growth of vascular smooth muscle cells. Journal of Clinical Investigation 1991 87 1889-1895. (doi:10.1172/JCI115213)
3. St-Arnaud R. The direct role of vitamin D on bone homeostasis. Archives of Biochemistry and Biophysics 2008 473 225-230. (doi:10.1016/j.abb.2008.03.038)
4. Uitterlinden AG, Fang Y, van Meurs JB, van Leeuwen H & Pols HA. Vitamin D receptor gene polymorphisms in relation to vitamin D related disease states. Journal of Steroid Biochemistry and Molecular Biology 2004 89-90 187-193. (doi:10.1016/j.jsbmb.2004.03.083)
5. Valdivielso JM & Fernandez E. Vitamin D receptor polymorphisms and diseases. Clinica Chimica Acta 2006 371 1-12. (doi:10.1016/j.cca.2006.02.016)
6. Uitterlinden AG, Ralston SH, Brandi ML, Carey AH, Grinberg D, Langdahl BL, Lips P, Lorenc R, Obermayer-Pietsch B, Reeve J, Reid DM, Amedei A, Bassiti A, Bustamante M, Husted LB, Diez-Perez A, Dobnig H, Dunning AM, Enjuanes A, Fahrleitner-Pammer A, Fang Y, Karczmarewicz E, Kruk M, van Leeuwen JP, Mavilia C, van Meurs JB, Mangion J, McGuigan FE, Pols HA, Renner W, Rivadeneira F, van Schoor NM, Scollen S, Sherlock RE & Ioannidis JP. The association between common vitamin D receptor gene variations and osteoporosis: a participant-level meta-analysis. Annals of Internal Medicine 2006 145 255-264. (Pubitemid 46768609)
7. Fang Y, van Meurs JB, d'Alesio A, Jhamai M, Zhao H, Rivadeneira F, Hofman A, van Leeuwen JP, Jehan F, Pols HA & Uitterlinden AG. Promoter and 3′-untranslated-region haplotypes in the vitamin D receptor gene predispose to osteoporotic fracture: the Rotterdam study. American Journal of Human Genetics 2005 77 807-823. (doi:10.1086/497438)
8. Muray S, Parisi E, Cardus A, Craver L & Fernandez E. Influence of vitamin D receptor gene polymorphisms and 25-hydroxyvitamin D on blood pressure in apparently healthy subjects. Journal of Hypertension 2003 21 2069-2075. (doi:10.1097/00004872-200311000-00016)
9. Filus A, Trzmiel A, Kuliczkowska-Plaksej J, Tworowska U, Jedrzejuk D, Milewicz A & Medras M. Relationship between vitamin D receptor BsmI and FokI polymorphisms and anthropometric and biochemical parameters describing metabolic syndrome. Aging Male 2008 11 134-139. (doi:10.1080/13685530802273426)
10. Testa A, Mallamaci F, Benedetto F, Pisano A, Tripepi G, Thadhani R & Zoccali C. Vitamin D receptor (VDR) gene polymorphism is associated with left ventricular (LV) mass and predicts LVH progression in end stage renal disease (ESRD) patients. Journal of Bone and Mineral Research 2010 25 313-319. (doi:10.1359/jbmr.090717)
11. Kammerer CM, Dualan AA, Samollow PB, Perisse AR, Bauer RL, MacCluer JW, O'Leary DH & Mitchell BD. Bone mineral density, carotid artery intimal medial thickness, and the vitamin D receptor BsmI polymorphism in Mexican American women. Calcified Tissue International 2004 75 292-298. (doi:10.1007/s00223-004-0215-9)
12. Ortlepp JR, Krantz C, Kimmel M, von Korff A, Vesper K, Schmitz F, Mevissen V, Janssens U, Franke A, Hanrath P, Zerres K & Hoffmann R. Additive effects of the chemokine receptor 2, vitamin D receptor, interleukin-6 polymorphisms and cardiovascular risk factors on the prevalence of myocardial infarction in patients below 65 years. International Journal of Cardiology 2005 105 90-95. (doi:10.1016/j.ijcard.2005.03.004)
13. Ortlepp JR, Lauscher J, Hoffmann R, Hanrath P & Joost HG. The vitamin D receptor gene variant is associated with the prevalence of type 2 diabetes mellitus and coronary artery disease. Diabetic Medicine 2001 18 842-845. (doi:10.1046/j.1464-5491.2001.00585.x) (Pubitemid 32953792)
14. Chiu KC, Chuang LM & Yoon C. The vitamin D receptor polymorphism in the translation initiation codon is a risk factor for insulin resistance in glucose tolerant Caucasians. BMC Medical Genetics 2001 2 2. (doi:10.1186/1471- 2350-2-2)
15. Oh JY & Barrett-Connor E. Association between vitamin D receptor polymorphism and type 2 diabetes or metabolic syndrome in community-dwelling older adults: the Rancho Bernardo Study. Metabolism 2002 51 356-359. (doi:10.1053/meta.2002.29969)
16. Kostner K, Denzer N, Muller CS, Klein R, Tilgen W & Reichrath J. The relevance of vitamin D receptor (VDR) gene polymorphisms for cancer: a review of the literature. Anticancer Research 2009 29 3511-3536.
17. Kuningas M, Mooijaart SP, Jolles J, Slagboom PE, Westendorp RG & van Heemst D. VDR gene variants associate with cognitive function and depressive symptoms in old age. Neurobiology of Aging 2009 30 466-473. (doi:10.1016/j. neurobiolaging.2007.07.001)
18. Deeg DJ, van Tilburg T, Smit JH & de Leeuw ED. Attrition in the Longitudinal Aging Study Amsterdam. The effect of differential inclusion in side studies. Journal of Clinical Epidemiology 2002 55 319-328. (doi:10.1016/S0895- 4356(01)00475-9)
19. Long JR, Zhao LJ, Liu PY, Dvornyk V, Shen H, Liu YJ, Zhang YY, Xiong DH, Xiao P & Denk HW. Patterns of linkage disequilibrium and haplotype distribution in disease candidate genes. BMC Genetics 2004 5 11. (doi:10.1186/1471-2156-5-11)
20. Nejentsev S, Godfrey L, Snook H, Rance H, Nutland S, Walker NM, Lam AC, Guja C, Ionescu-Tirgoviste C, Undlien DE, Ronningen KS, Tuomilehto-Wolf E, Tuomilehto J, Newport MJ, Clayton DG & Todd JA. Comparative high-resolution analysis of linkage disequilibrium and tag single nucleotide polymorphisms between populations in the vitamin D receptor gene. Human Molecular Genetics 2004 13 1633-1639. (doi:10.1093/hmg/ddh169)
21. Fang Y, van Meurs JB, Rivadeneira F, van Schoor NM, van Leeuwen JP, Lips P, Pols HA & Uitterlinden AG. Vitamin D receptor gene haplotype is associated with body height and bone size. Journal of Clinical Endocrinology and Metabolism 2007 92 1491-1501. (doi:10.1210/jc.2006-1134)
22. Stephens M, Smith NJ & Donnelly P. A new statistical method for haplotype reconstruction from population data. American Journal of Human Genetics 2001 68 978-989. (doi:10.1086/319501)
23. Pencina MJ, D'Agostino RB Sr, Larson MG, Massaro JM & Vasan RS. Predicting the 30-year risk of cardiovascular disease: the Framingham Heart study. Circulation 2009 119 3078-3084. (doi:10.1161/CIRCULATIONAHA.108.816694)
24. Smolders J, Damoiseaux J, Menheere P, Tervaert JW & Hupperts R. Association study on two vitamin D receptor gene polymorphisms and vitamin D metabolites in multiple sclerosis. Annals of the New York Academy of Sciences 2009 1173 515-520. (doi:10.1111/j.1749-6632.2009.04656.x)
25. Smolders J, Damoiseaux J, Menheere P, Tervaert JW & Hupperts R. Fok-I vitamin D receptor gene polymorphism (rs10735810) and vitamin D metabolism in multiple sclerosis. Journal of Neuroimmunology 2009 207 117-121. (doi:10.1016/j.jneuroim.2008.12.011)
26. Engelman CD, Fingerlin TE, Langefeld CD, Hicks PJ, Rich SS, Wagenknecht LE, Bowden DW & Norris JM. Genetic and environmental determinants of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels in Hispanic and African Americans. Journal of Clinical Endocrinology and Metabolism 2008 93 3381-3388. (doi:10.1210/jc.2007-2702)
27. Flegal KM, Graubard BI, Williamson DF & Gail MH. Excess deaths associated with underweight, overweight, and obesity. Journal of the American Medical Association 2005 293 1861-1867. (doi:10.1001/jama.293.15.1861)
28. Melamed ML, Michos ED, Post W & Astor B. 25-Hydroxyvitamin D levels and the risk of mortality in the general population. Archives of Internal Medicine 2008 168 1629-1637. (doi:10.1001/archinte.168.15.1629)
29. Uitterlinden AG, Pols HA, Burger H, Huang Q, Van Daele PL, van Duijn CM, Hofman A, Birkenhager JC & van Leeuwen JP. A large-scale population-based study of the association of vitamin D receptor gene polymorphisms with bone mineral density. Journal of Bone and Mineral Research 1996 11 1241-1248. (doi:10.1002/jbmr.5650110908)
30. Sterne JA, White IR, Carlin JB, Spratt M, Royston P, Kenward MG, Wood AM & Carpenter JR. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ 2009 338 b2393. (doi:10.1136/bmj.b2393)
31. 3 responsiveness and non-familial susceptibility in psoriasis. Pharmacogenetics and Genomics 2005 15 349-355. (doi:10.1097/01213011-200505000-00011)
32. Halsall JA, Osborne JE, Potter L, Pringle JH & Hutchinson PE. A novel polymorphism in the 1A promoter region of the vitamin D receptor is associated with altered susceptibility and prognosis in malignant melanoma. British Journal of Cancer 2004 91 765-770. (doi:10.1038/sj.bjc.6602006)
33. Esterle L, Jehan F, Sabatier JP & Garabedian M. Higher milk requirements for bone mineral accrual in adolescent girls bearing specific Caucasian genotypes in the VDR promoter. Journal of Bone and Mineral Research 2009 24 1389-1397. (doi:10.1359/jbmr.090301)
34. Cooper C, Atkinson EJ, Jacobsen SJ, O'Fallon WM & Melton LJ III. Population-based study of survival after osteoporotic fractures. American Journal of Epidemiology 1993 137 1001-1005.
35. Cauley JA, Thompson DE, Ensrud KC, Scott JC & Black D. Risk of mortality following clinical fractures. Osteoporosis International 2000 11 556-561. (doi:10.1007/s001980070075)
36. Center JR, Nguyen TV, Schneider D, Sambrook PN & Eisman JA. Mortality after all major types of osteoporotic fracture in men and women: an observational study. Lancet 1999 353 878-882. (doi:10.1016/S0140-6736(98)09075- 8)
37. Marco MP, Craver L, Betriu A, Fibla J & Fernandez E. Influence of vitamin D receptor gene polymorphisms on mortality risk in hemodialysis patients. American Journal of Kidney Diseases 2001 38 965-974. (doi:10.1053/ajkd.2001.28582)
38. Tworowska-Bardzinska U, Lwow F, Kubicka E, Laczmanski L, Jedzrzejuk D, Dunajska K & Milewicz A. The vitamin D receptor gene BsmI polymorphism is not associated with anthropometric and biochemical parameters describing metabolic syndrome in postmenopausal women. Gynecological Endocrinology 2008 24 514-518. (doi:10.1080/09513590802302985)
39. Uitterlinden AG, Fang Y, van Meurs JB, Pols HA & van Leeuwen JP. Genetics and biology of vitamin D receptor polymorphisms. Gene 2004 338 143-156. (doi:10.1016/j.gene.2004.05.014)